dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Totland, Max Zachrisson |
dc.contributor.author | Omori, Yasufumi |
dc.contributor.author | Sørensen, Vigdis |
dc.contributor.author | Kryeziu, Kushtrim |
dc.contributor.author | Brech, Andreas |
dc.contributor.author | Aasen, Trond |
dc.date.accessioned | 2023-08-21T09:46:08Z |
dc.date.available | 2023-08-21T09:46:08Z |
dc.date.issued | 2023-10 |
dc.identifier.citation | Totland MZ, Omori Y, Sørensen V, Kryeziu K, Aasen T, Brech A, et al. Endocytic trafficking of connexins in cancer pathogenesis. Biochim Biophys Acta - Mol Basis Dis. 2023 Oct;1869(7):166812. |
dc.identifier.issn | 0925-4439 |
dc.identifier.uri | https://hdl.handle.net/11351/10104 |
dc.description | Càncer; Connexina; Ubiquitina |
dc.description.sponsorship | E. Leithe acknowledges funding from the South-Eastern Norway Regional Health Authority (grant number 2016013) and the Kristian Gerhard Jebsen Foundation. T. Aasen acknowledges funding from Instituto de Salud Carlos III, grant PI21/00470 co-financed by the European Regional Development Fund (ERDF). |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;1869(7) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer |
dc.subject | Connexines - Metabolisme |
dc.subject | Unions gap (Biologia cel·lular) |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | Gap Junctions |
dc.subject.mesh | Connexins |
dc.title | Endocytic trafficking of connexins in cancer pathogenesis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.bbadis.2023.166812 |
dc.subject.decs | neoplasias |
dc.subject.decs | uniones comunicantes |
dc.subject.decs | conexinas |
dc.relation.publishversion | https://doi.org/10.1016/j.bbadis.2023.166812 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Totland MZ, Kryeziu K] Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. [Omori Y] Department of Molecular and Tumour Pathology, Akita University Graduate School of Medicine, Akita, Japan. [Sørensen V] Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. [Aasen T] Grup de Recerca de Patologia Molecular Translacional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Brech A] Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway. Section for Physiology and Cell Biology, Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway |
dc.identifier.pmid | 37454772 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI21%2F00470 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |